<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8809320</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1600</journal-id>
<journal-id journal-id-type="nlm-ta">Neuron</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuron</journal-id>
<journal-title-group>
<journal-title>Neuron</journal-title>
</journal-title-group>
<issn pub-type="ppub">0896-6273</issn>
<issn pub-type="epub">1097-4199</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30946830</article-id>
<article-id pub-id-type="pmc">6482287</article-id>
<article-id pub-id-type="doi">10.1016/j.neuron.2019.03.022</article-id>
<article-id pub-id-type="manuscript">NIHMS1524527</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Uncovering the genetic architecture of major depression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>McIntosh</surname>
<given-names>Andrew M</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sullivan</surname>
<given-names>Patrick F</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lewis</surname>
<given-names>Cathryn M</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1.</label>Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK</aff>
<aff id="A2"><label>2.</label>Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK</aff>
<aff id="A3"><label>3.</label>Departments of Genetics and Psychiatry, University of North Carolina, Chapel Hill, NC, USA</aff>
<aff id="A4"><label>4.</label>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden</aff>
<aff id="A5"><label>5.</label>Social, Genetic and Developmental Psychiatry Centre, King’s College London, London, UK</aff>
<aff id="A6"><label>6.</label>Department of Medical and Molecular Genetics, King’s College London, London UK</aff>
<author-notes>
<corresp id="CR1"><label>*</label><bold>Address for correspondence</bold> Andrew M McIntosh, <email>andrew.mcintosh@ed.ac.uk</email> , Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh EH10 5HF, UK</corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P40">Declaration of interests</p>
<p id="P41">AMM currently receives research support from the Sackler Trust and has received past support from Eli Lilly and Janssen within the last 3 years. PFS reports the following potentially competing financial interests. Current: Lundbeck (advisory committee, grant recipient). Past three years: Pfizer (scientific advisory board), Element Genomics (consultation fee), and Roche (speaker reimbursement). CML receives research support from Eli Lilly and RGA Re-insurance.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>21</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>03</day>
<month>4</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>03</day>
<month>4</month>
<year>2020</year>
</pub-date>
<volume>102</volume>
<issue>1</issue>
<fpage>91</fpage>
<lpage>103</lpage>
<!--elocation-id from pubmed: 10.1016/j.neuron.2019.03.022-->
<abstract id="ABS1">
<p id="P1">There have been several recent studies addressing the genetic architecture of depression. This review serves to take stock of what is known now about the genetics of depression, how it has increased our knowledge and understanding of its mechanisms and how the information and knowledge can be leveraged to improve the care of people affected. We identify four priorities for how the field of MD genetics research may move forward in future years, namely by increasing the sample sizes available for genome-wide association studies (GWAS), greater inclusion of diverse ancestries and low-income countries, the closer integration of psychiatric genetics with electronic medical records and developing the neuroscience toolkit for polygenic disorders.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>